Medpace Holdings Inc
Healthcare · EUR · F
Price
€370.232
Cap
€12.11B
Earnings
—
30d Trend
-14.5%
62% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 56×Macro 0.99 (−1%)=55
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 6.2% yield
BRAIN47'S ASSESSMENT
I rate Medpace Holdings Inc at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 73/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+8.3%
3 MONTHS
-0.8%
12 MONTHS
+50.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 6.2% yield. Quality (73) and Momentum (58) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 62%. I classify this as an income position — the 6.2% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.